Mark N. Lampert, 10% Owner at Capstone Therapeutics Corp. (CAPS), bought 78,900 shares at $0.26 ($21K) on 2011-08-18, disclosed to the SEC on 2011-08-22.
Open-market purchase of $21k CAPS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.26 | 31,200 | $8K | 39.5% |
| 2 | $0.26 | 3,100 | $806 | 3.9% |
| 3 | $0.26 | 8,000 | $2K | 10.1% |
| 4 | $0.26 | 27,800 | $7K | 35.2% |
| 5 | $0.26 | 1,200 | $312 | 1.5% |
| 6 | $0.26 | 1,900 |
| $494 |
| 2.4% |
| 7 | $0.26 | 5,700 | $1K | 7.2% |
| Total | $0.26 avg | 78,900 | $21K | 100% |
| Filing → |
| MRUS | BUY | 2021-03-18 | $5.8M | — | Filing → |
| XOMA | BUY | 2019-12-20 | $8.2M | — | Filing → |
| CALA | BUY | 2019-11-22 | $1.5M | — | Filing → |